← Eichor
Study identifier: NCT07666204 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Using Sensorimotor Reorganization Following Upper Limb Amputation to Improve Prosthetic Control

Condition: Amputation of Upper Limb · Agenesis of Upper Limb  ·  Sponsor: Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Amputation of an upper limb results in a disruption of the sensorimotor loop and a reorganization of the nervous system, leading to the emergence of a phantom limb and the adaptation of compensatory motor strategies. This project aims to leverage these phenomena (induced sensations, phantom mobility, and compensations) to improve control, sensory feedback, and the appropriation of prostheses, in order to reduce cognitive load and musculoskeletal disorders.

This description comes directly from the study's public registry record.

Talk to the study team

Amélie Touillet  ·  +333 83 52 97 00  ·  amelie.touillet@ugecam.assurance-maladie.fr

Jonathan Pierret, PhD  ·  +333 83 52 97 00  ·  jonathan.pierret@ugecam.assurance-maladie.fr

Always discuss trial participation with your own doctor first.

Locations (2)

Institut Régional de Médecine Physique et de Réadaptation, Filière LocomoteurNancy, FranceRecruiting
Fondation Saint-HélierRennes, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07666204